Universe Pharmaceuticals Inc. Class A Ordinary Shares
UPC
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
Last trade$1.52
Day change+$0.035 (+2.36%)
Day range$1.35 – $1.54
Volume10,465
Market cap$7M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
No ratio data was found for UPC.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
No quarterly
income statement data was found for UPC.
Recent news
Company coverage with links to the original publishers.
Universe Pharmaceuticals INC, a Chinese pharmaceutical company, received a notification from Nasdaq that it is not in compliance with the minimum bid price requirement for continued listing. The company has 180 days to regain compliance by maintaining a closing bid price of at least $1.00 per share for 10 consecutive business days.
Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.
Fluor posted adjusted earnings of 68 cents per share, beating market estimates of 57 cents per share. The company’s quarterly sales came in at $3.82 billion versus expectations of $4.11 billion.
Fluor shares declined 7.7% to $38.84 on Tuesday.
Here are some other stocks moving in today's mid-day session.
Gainers
TRxADE HEALTH, Inc. (NASDAQ: MEDS) shares jumped 214% to $13.00. TRxADE HEALTH announced the sale of assets of subsidiary Trxade, Inc. to Micro Merchant Systems for $22.5 million, with potential additional $7.5 million payout.
AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) surged 203% to $0.6487. AgriFORCE was granted patent from the USPTO related to its FORCEGH+ facilities.
Monopar Therapeutics Inc. (NASDAQ: MNPR) shares jumped 170% to $0.9130. Monopar received clearance to proceed with first-in-human Phase 1 trial of novel radiopharmaceutical MNPR-101-Zr in advanced cancers.
Biofrontera Inc. (NASDAQ: BFRI) gained 125% to $1.69. Biofrontera announced restructuring of supply agreement with Biofronter AG. Biofrontera also announced a $16 million private placement.
Biotricity, Inc. (NASDAQ: BTCY) rose 72.7% to $1.59.
Shineco, Inc. (NASDAQ: SISI) shares climbed 71.8% to $2.5232 after surging more than 16% on Friday. Shineco recently announced plans for a 1-for-10 reverse stock split to regain compliance with Nasdaq minimum bid requirement.
SciSparc Ltd. (NASDAQ: SPRC) gained 52.7% to $5.32. SciSparc reported that as part of its ongoing collaboration with Clearmind Medicine, Clearmind filed three patent applications under the international Patent Cooperation Treaty.
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) shares rose 37% to $12.55. WuXi Advanced Therapies announced Tuesday that the U.S. Food and Drug Administration (FDA) approved it to begin analytical testing and manufacturing of AMTAGVI for Iovance Biotherapeutics at its Philadelphia site. AMTAGVI received accelerated approval of its BLA on Feb. 16. Iovance also ...
Shares of Discover Financial Services (NYSE: DFS) shares rose sharply in today’s pre-market trading.
Capital One Financial Corp (NYSE: COF) announced its plans to purchase Discover Financial Services, marking a pivotal $35.3 billion all-stock transaction.
As per the terms of the deal, Discover shareholders are slated to receive 1.0192 shares of Capital One for every share they hold, translating to a 26% premium over Discover's last closing price.
Discover Financial Services shares jumped 11.2% to $122.88 in pre-market trading
Here are some other stocks moving in pre-market trading.
Gainers
AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) gained 283.1% to $0.82 in pre-market trading. AgriFORCE was granted patent from the USPTO related to its FORCEGH+ facilities
Shineco, Inc. (NASDAQ: SISI) shares jumped 156% to $3.77 in pre-market trading after surging more than 16% on Friday. Shineco recently announced plans for a 1-for-10 reverse stock split to regain compliance with Nasdaq minimum bid requirement.
TRxADE HEALTH, Inc. (NASDAQ: MEDS) shares rose 100.4% to $8.30 in pre-market trading. TRxADE HEALTH announced the sale of ...
Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates.
Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41.
RxSight shares jumped 20% to $44.31 on Monday.
Here are some other stocks moving in today's mid-day session.
Gainers
Harpoon Therapeutics, Inc. (NASDAQ: HARP) shares jumped 111.2% to $22.28 after Merck announced it will acquire the company for $23 per share in cash.
Ambrx Biopharma Inc. (NASDAQ: AMAM) jumped 98.1% to $27.00 after Johnson & Johnson announced it will acquire the company in an all-cash merger for a total equity value of approximately $2 billion.
Spectaire Holdings Inc. (NASDAQ: SPEC) jumped 75.2% to $2.96.
Nkarta, Inc. (NASDAQ: NKTX) rose 51% to $9.17 as the company announced updated corporate presentation to reflect business and strategic update.
Universe Pharmaceuticals INC (NASDAQ: UPC) gained 42% to $2.22.
Elevation Oncology, Inc. (NASDAQ: ELEV) jumped 39.2% to $1.2193.
NexImmune, Inc. (NASDAQ: NEXI) rose 34.7% to $8.32.
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) rose 34% to $33.76 as the company issued update on advancing clinical stage portfolio.
QuantaSing Group Limited (NASDAQ: QSG) gained 31% to $2.0563.
Butterfly Network, Inc. (NASDAQ: BFLY) rose 29.7% to $1.31 as the company announced FDA clearance of handheld ultrasound system, Butterfly iQ3.
Venus Concept Inc. (NASDAQ: VERO) climbed 28% to $1.51.
Ardelyx, Inc. (NASDAQ: ARDX) gained 25.5% to $7.73 after the company provided an update on its progress in 2023 and initial expectations for 2024.
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 20.8% to $7.36 after the company issued preliminary Q4 revenue guidance above estimates. Also the company said it is approaching positive EPS and cash flow in 2H 2025.
Axonics, Inc. (NASDAQ: AXNX) jumped 19.9% to $69.03 after the company announced a deal to be acquired by Boston Scientific.
Crocs, Inc. (NASDAQ: CROX) jumped 18.8% to $102.69 after the company issued strong Q4 and full year 2023 guidance.
LendingTree, Inc. (NASDAQ: TREE) ...
Jiangxi, China, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the Company received a written notification (the “Notification Letter”) from the Nasdaq Stock Market LLC (“Nasdaq”) on August 1, 2023, notifying the Company that it is not in compliance with the minimum Market Value of Publicly Held Shares (“MVPHS”) requirement set forth in the Nasdaq Listing Rules for continued listing on the Nasdaq Global Market.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
Ex-dividend
Amount / share
Pay date
Type
Apr 29, 2004
$1,200.24
May 17, 2004
unknown
Jan 29, 2004
$1,200.24
Feb 17, 2004
unknown
Stock splits
Historical share-structure events and their execution dates.